Sunday, July 6, 2014

Hot Tech Stocks To Invest In Right Now

A rare opportunity came my way in October when Google unveiled its Internet-surfing, voice and gesture-controlling eye glasses to the public for the first time in Durham, N.C., near where I live.

I'd heard (and written) about wearable technology and its power to access many apps and programs on a computer or smartphone without using hands.

But it wasn't until Google Glass was on my face, and a Glass Guide was talking me through its functions and features, that I really got it. Glass is like an add-on to my brain.

That got me thinking about the 10,000 men and women given the chance to buy Glass and test it in the past six months. These "Explorers" got a head start on developing the apps, called 'Glassware,' that will make the gadget the biggest innovation in mobile technology since the cellphone.

Top 10 Oil Service Stocks To Watch Right Now: Autobytel Inc.(ABTL)

Autobytel Inc. operates as an automotive marketing services company in the United States. It assists automotive retail dealers and manufacturers to market and sell new and used vehicles to consumers through its online purchase request referrals, dealer marketing products and services, and online advertising programs and data products. The company provides vehicle purchase request programs, including new vehicle purchase request program, which allows consumers to submit requests for pricing and availability of specific makes and models; used vehicle purchase request program that allows consumers to search for used vehicles according to specific search parameters, such as the price, make, model, mileage, year, and location of the vehicle; and finance purchase request program designed to provide consumers the opportunity to obtain vehicle financing and other services from dealers or finance institutions. Its network of company-owned consumer-facing automotive Websites compris e Autobytel.com, which provide consumers the information and tools to aid them with their automotive purchase decisions and the ability to submit inquiries requesting dealers to contact the consumers for purchasing or leasing vehicles. In addition, the company provides products and services that assist dealers in connecting with in-market consumers and closing vehicle sales. The company, formerly known as Autobytel.com Inc., was founded in 1995 and is headquartered in Irvine, California.

Advisors' Opinion:
  • [By Louis Navellier]

    Here are some candidates for some “best of the best” stock picks that should do well and help lead you to a profitable 2014.

    ‘Best of the Best’ Stock Picks #1: Autobytel (ABTL)

    Autobytel (ABTL) is an automotive marketing services company that helps dealers find customers through its online referral services. ABTL provides vehicle lead programs, including new vehicle search, which essentially allows you and I to submit requests for things like price and availability of specific makes and models of different automobiles. Autobytel also has a used vehicle lead program that allows people to similarly search for used cars.

Hot Tech Stocks To Invest In Right Now: Semiconductor Manufacturing International Corporation(SMI)

Semiconductor Manufacturing International Corporation, an investment holding company, engages in the computer-aided design, manufacture, packaging, testing, and trade of integrated circuits. It offers a range of technologies from 0.35μm to 65nm with capabilities that include logic, mixed signal/RF CMOS, high voltage, embedded, flash, EEPROM, and CIS technology. The company also provides portfolio of semiconductor intellectual property (IP) blocks from 0.35um to 65nm to support the design needs of customers; ASIC design services; reference flows; mixed-signal/RF PDKs; and multi-project wafer services. In addition, it involves in the design and manufacture of semiconductor masks; and provides assembly and testing, wafer bumping, and wafer probing/testing services. Further, the company offers marketing related activities; operates convenience stores; and manufactures and trades in solar cell related semiconductor products. Its products are used primarily in mobile, network ing, and wireless local area network applications, as well as in consumer and communications products, including digital television, set-top box, mobile, portable media player, and personal digital assistant applications. The company serves integrated device manufacturers, fables semiconductor companies, and system companies principally in the United States, Europe, and the Asia Pacific. Semiconductor Manufacturing International Corporation was founded in 2000 and is headquartered in Shanghai, the People?s Republic of China.

Advisors' Opinion:
  • [By Inyoung Hwang]

    National benchmark indexes advanced in 13 of the 18 western European markets this week. France�� CAC 40 Index climbed 1.2 percent and Germany�� DAX Index increased 0.6 percent. The U.K.�� FTSE 100 Index sank 1.3 percent, while the Swiss Market Index (SMI) retreated 0.2 percent.

  • [By Tom Stoukas]

    The Swiss Market Index (SMI) rose 0.1 percent to 8,055.23 at the close in Zurich. The equity benchmark has climbed 4 percent this month, extending its gain this quarter to 4.8 percent, as the Federal Reserve refrained from reducing its monthly bond purchases. The gauge has rallied 18 percent so far in 2013, the third-best performance by a European developed market. The Swiss Performance Index gained less than 0.1 percent today.

  • [By Pato Kehoe]

    In an attempt to trim costs and increase its operational efficiencies, Estee Lauder�� business strategy last year focused on centralizing its core operating functions, as well as reducing non-profitable stock keeping units. The cost reduction program, Strategic Modernization Initiative (SMI), proved highly efficient, saving the company $781 million in 2013. Furthermore, while the program will continue throughout 2014, management announced that it would be reinvesting a large amount of the cost savings in marketing for its core brands, along with product innovation. In this regard, decentralizing innovation to better adjust to its global customer preferences, is and will continue to be a key strategy in further propelling the beauty giant�� growth.

  • [By Corinne Gretler]

    Nestle decreased 2.6 percent to 63 francs, contributing the most to the SMI (SMI)�� drop. Revenue in the first half increased 4.1 percent, excluding acquisitions, divestments and currency shifts. That missed the median estimate of 4.5 percent growth.

Hot Tech Stocks To Invest In Right Now: Verisk Analytics Inc (VRSK)

Verisk Analytics, Inc. (Verisk) is a provider of information about risk to professionals in insurance, healthcare, mortgage, government, supply chain, and risk management. Verisk enable risk-bearing businesses to understand and manage their risks. The Company provides its customers by supplying data that, combined with its analytic methods, creates embedded decision support solutions. Verisk organizes its business in two segments: Risk Assessment and Decision Analytics. Its Risk Assessment segment provides statistical, actuarial and underwriting data for the United States property and casualty (P&C) insurance industry. Its Decision Analytics segment provides solutions its customers use to analyze the processes of the Verisk Risk Analysis Framework: Prediction of Loss, Detection and Prevention of Fraud, and Quantification of Loss. On June 17, 2011, it acquired the net assets of Health Risk Partners, LLC (HRP). On April 27, 2011, it acquired 100% interest of Bloodhound Technologies, Inc. (Bloodhound).

Risk Assessment Segment

Verisk�� Risk Assessment segment serves P&C insurance customers and focuses on the first two decision making processes in its Risk Analysis Framework: loss prediction, and selection and pricing of risk. The Company also provides solutions to help its insurance customers comply with their reporting requirements in each United States in which they operate. The Company�� customer includes most of the P&C insurance providers in the United States. It aggregates the data and, as a licensed statistical agent in all 50 states, Puerto Rico and the District of Columbia, it reports these statistics to insurance regulators. The Company uses its technology to assemble, organize and update amounts of detailed information submitted by its customers. It supplements this data with publicly available information. Each year, P&C insurers send the Company approximately 2.9 billion detailed individual records of insurance transactions, such as insurance premiums collected ! or losses incurred. It maintains a database of over 15.8 billion statistical records, including approximately 6.1 billion commercial lines records and approximately 9.7 billion personal lines records. It collects unit-transaction detail of each premium and loss record, which enhances the validity, reliability and accuracy of the data sets and its actuarial analyses.

The Company provides actuarial services to help its customers price their risks as they underwrite. It projects future losses and loss expenses utilizing a range of data. It provides loss costs by coverage, class, territory, and many other categories. Its customers can use its estimates of future loss costs in making independent decisions about the prices charged for their policies. It makes a number of actuarial adjustments, including loss development and loss adjustment expenses before the data is used to estimate future loss costs. Its actuarial services are also used to create the analytics underlying its industry-standard insurance programs. In addition, its actuarial consultants provide customized services for its clients, which include assisting them with the development of independent insurance programs, analysis of their own underwriting experience, development of classification systems and rating plans, and a wide variety of other business decisions. It also supplies information to a range of customers in other markets, including reinsurance, government agencies and real estate.

The Company gathers information on individual properties and communities. Its property-specific rating and underwriting information allow the customers to understand, quantify, underwrite, mitigate, and avoid potential loss for residential and commercial properties. Its database contains loss costs and other vital information on over 3.3 million commercial buildings in the United States and also holds information on more than six million individual businesses occupying those buildings. It also provides analytic measures of the ab! ility of ! individual communities to mitigate losses from important perils. It provides field-verified and validated data on the fire protection services for more than 46,000 fire response jurisdictions. It also offers services to evaluate the effectiveness of community enforcement of building codes. It provides information on the insurance rating territories, premium taxes, crime risk, and hazards of windstorm, earthquake, wildfire, and other perils.

The Company competes with National Independent Statistical Service, the Independent Statistical Service, American Association of Insurance Services, Mutual Services Organization, Overland Solutions, Inc., Regional Reporting, Inc., CDS, Inc., Deloitte Consulting LLP, Pinnacle Consulting and EMB.

Decision Analytics Segment

In the Decision Analytics segment, the Company supports all four phases of its Risk Analysis Framework. It develops predictive models to forecast scenarios and produce both standard and customized analytics. It is a provider of fraud-detection tools for the P&C insurance industry. Its fraud solutions improve its customers��profitability by both predicting the likelihood that fraud is occurring and detecting suspicious activity after it has occurred. When a claim is submitted, its system searches its database and returns information about other claims filed by the same individuals or businesses (either as claimants or insurers), which help the customers determine if fraud has occurred. Its system also includes name and address searching to perform intelligent searches and improve the overall quality of the matches.

The Company provides data, analytic and networking products for professionals involved in estimating all phases of building repair and reconstruction. It provides solutions for every phase of a building�� life, including quantifying the ultimate cost of repair or reconstruction of damaged or destroyed buildings; aiding in the settlement of insurance claims, and tracking the process o! f repair ! or reconstruction and facilitating communication among insurers, adjusters, contractors and policyholders. It also offers customers access to wholesale and retail price lists, which include structural repair and restoration pricing for 467 separate economic areas in North America.

The Company�� database contains information on nearly 800 million claims. Insurers and other participants submit new claim reports, more than 239,000 a day on average, across all categories of the United States P&C insurance industry. It also provides a service allowing insurers to report thefts of automobiles and property; a service that helps owners and insurers recover stolen heavy construction and agricultural equipment; a scoring system that helps distinguish between suspicious and meritorious claims, and products that use link-analysis technology to help visualize and fight insurance fraud. The Company is a provider of automated fraud detection, compliance and decision-support tools for the mortgage industry. Utilizing its own loan level application database combined with actual mortgage loan performance data, it has established a risk scoring system which increases its customers��ability to detect fraud.

The Company provides solutions that detect fraud through each step of the mortgage lifecycle and provide regulatory compliance solutions that perform instant compliance reviews of each mortgage application. Its database contains more than 21 million current and historical loan applications collected over the past ten years. This database contains data from loan applications, as well as supplementary third-party data. It also provides forensic audit services for the mortgage origination and mortgage insurance industries. Its predictive screening tools predict, which defaulted loans are the candidates for full audits for the purpose of detecting fraud.

The Company offers solutions that help healthcare claims payors detect fraud, abuse and overpayment. It runs its customers��cla! ims throu! gh its analytic system to identify potential fraud, abuse and overpayment, and then a registered nurse, physician or other clinical specialist skilled in coding and reimbursement decisions reviews all suspect claims and billing patterns. It analyzes the patterns of claims produced by individual physicians, physicians��practices, hospitals, dentists, and pharmacies to locate the sources of fraud. It also offers Web-based reporting tools that let payors take definitive action to prevent overpayments or payment of fraudulent claims. The tools provide the documentation that helps to identify, investigate and prevent abusive and fraudulent activity by providers.

The Company is a provider of healthcare business intelligence and predictive modeling. It provides analytical and reporting systems to health insurers, provider organizations and self-insured employers. Those organizations use its solutions to review their healthcare data, including information on claims, membership, providers and utilization, and provide cost trends, forecasts and actuarial, financial and utilization analyses. It also provides its customers healthcare services using complex clinical analyses to uncover reasons behind cost and utilization increases. It provides financial and actuarial analyses, clinical, technical and implementation services and training services to help its customers manage costs and risks to their practices.

The Company competes with Risk Management Solutions, LexisNexis Risk Solutions, MSB, Solera, Computer Sciences Corporation, Fair Isaac Corporation, OptumInsight, McKesson, Medstat, MedAssurant, iHealth, CoreLogic and DataVerify Corporation.

Advisors' Opinion:
  • [By WWW.GURUFOCUS.COM]

    Shares of Verisk Analytics, Inc. (VRSK), a provider of data and analytics to insurance, health care and financial end markets, declined on tepid results for the fourth quarter 2013. Trends in its health care unit improved modestly, although this strength was offset by slightly slower growth in its core insurance units. Verisk is investing aggressively across its businesses to broaden and deepen its set of data and analytics, particularly in healthcare, where we believe the long-term opportunity is significant. While this investment weighs on near-term margins, we are confident that this strategy will lead to sustained organic growth.

  • [By Lauren Pollock]

    Verisk Analytics Inc.(VRSK) agreed to acquire EagleView Technology Corp. for $637 million, a move the company expects will enhance its position in the imagery analytics market.

Hot Tech Stocks To Invest In Right Now: Xilinx Inc (XLNX)

Xilinx, Inc. (Xilinx), incorporated on February 5, 1984, designs, develops and markets programmable platforms. These programmable platforms have a number of components, including integrated circuits (ICs) in the form of programmable logic devices (PLDs), including Extensible Processing Platforms (EPPs); software design tools to program the PLDs; targeted reference designs; printed circuit boards, and intellectual property (IP), which consists of Xilinx and various third-party verification and IP cores. In addition to its programmable platforms, Xilinx provides design services, customer training, field engineering and technical support. The Company�� PLDs include field programmable gate arrays (FPGAs), complex programmable logic devices (CPLDs) that its customers program to perform logic functions, and EPPs. Xilinx�� products are offered to electronic equipment manufacturers in end markets, such as wired and wireless communications, industrial, scientific and medical, aerospace and defense, audio, video and broadcast, consumer, automotive and data processing. The Company sells its products globally through independent domestic and foreign distributors and through direct sales to original equipment manufacturers (OEMs) by a network of independent sales representative firms and by a direct sales management organization. In January 2011, the Company acquired AutoESL Design Technologies, Inc. In August 2012, the Company acquired embedded Linux solutions provider PetaLogix.

Product Families

The 7 series devices that comprise the Company�� 28-nanometer (nm) product families are fabricated on a high-K metal gate 28-nm process technology. These devices are based on an architecture, which enables design and IP portability and re-use across all families, as well as provides designers the ability to achieve the appropriate combination of I/O support, performance, feature quantities, packaging and power consumption to address a range of applications. The 7 series devices consist of! three families: Virtex-7 FPGA, Kintex-7 FPGAs and Artix-7 FPGAs. The Zynq-7000 family is the family of Xilinx EPPs. The Virtex-6 FPGA family consists of 13 devices and is the sixth generation in the Virtex series of FPGAs.

Virtex-6 FPGAs are fabricated on a high-performance, 40-nm process technology. There are three Virtex-6 families: Virtex-6 LXT FPGAs, Virtex-6 SXT FPGAs and Virtex-6 HXT FPGAs. The Spartan-6 family is the PLD industry�� 45-nm high-volume FPGA family, consisting of 11 devices in two product families: Spartan-6 LX FPGAs and Spartan-6 LXT FPGAs. The Virtex-5 FPGA family consists of 26 devices in five product families: Virtex-5 LX FPGAs for logic-intensive designs, Virtex-5 LXT FPGAs for high-performance logic with serial connectivity, Virtex-5 SXT FPGAs for high-performance DSP with serial connectivity, Virtex-5 FXT FPGAs for embedded processing with serial connectivity and Virtex-5 TXT FPGAs for high-bandwidth serial connectivity. Prior generation Virtex families include Virtex-4, Virtex-II Pro, Virtex-II, Virtex-E and the original Virtex family. Spartan family FPGAs include 90-nm Spartan-3 FPGAs, the Spartan-3E family and the Spartan-3A family. Prior generation Spartan families include Spartan-IIE, Spartan-II, Spartan XL and the original Spartan family.

Design Platforms and Services

The Company offers three types of programmable platforms. The Base Platform is the delivery vehicle for all of its new silicon offerings used to develop and run customer-specific software applications and hardware designs. The Base Platform consists of FPGA silicon; Integrated Software Environment (ISE) Design Suite design environment; integration support of optional third-party synthesis, simulation, and signal integrity tools; reference designs; development boards and IP. The Domain-Specific Platform targets one of the three primary Xilinx FPGA user profiles: the embedded processing developer; the DSP developer; or the logic/connectivity developer. The Market-S! pecific P! latform enables software or hardware developers to build and run their specific application or solution. Built for specific markets, such as automotive, consumer, aerospace and defense, communications, audio, video and broadcast, industrial, or scientific and medical, the Market-Specific Platform integrates both the Base and Domain-Specific Platforms.

During April 2012, Xilinx introduced the Vivado Design Suite. Vivado supports Xilinx 7 series FPGAs and Zynq EPPs. Xilinx and various third parties offer hundreds of no charge and fee-bearing IP core licenses covering Ethernet, memory controllers Interlaken and PCIe interface, as well as domain-specific IP in the areas of embedded, DSP and connectivity, and market-specific IP cores. The Company also offers development kits, including hardware, design tools, IP and reference designs. Xilinx offers a range of configuration products, including one-time programmable and in-system programmable storage devices to configure Xilinx FPGAs. These programmable read-only memory (PROM) products support all of the Company�� FPGA devices. Xilinx and certain third parties have developed and offer a ecosystem of IP, boards, tools, services and support through the Xilinx alliance program. Xilinx also works with these third parties to promote its programmable platforms through third-party tools, IP, software, boards and design services. Xilinx engineering services provide customers with engineering, ranging from hands-on training to full design creation and implementation.

The Company competes with Altera Corporation, Lattice Semiconductor Corporation and Microsemi Corporation.

Advisors' Opinion:
  • [By Lee Jackson]

    Xilinx Inc. (NASDAQ: XLNX) was recently raised to an overweight rating at Morgan Stanley (NYSE: MS) and should be able to contain any earnings degradation as a result from lowered orders from Cisco. The consensus price target for the stock stands at $47, and investors are paid a 2.2% dividend.

  • [By Monica Gerson]

    Xilinx (NASDAQ: XLNX) dipped 3.03% to $46.10 after the company issued a weak current-quarter revenue outlook.

    Posted-In: PreMarket LosersNews Movers & Shakers Pre-Market Outlook Markets

Hot Tech Stocks To Invest In Right Now: Cellular Dynamics International Inc (ICEL)

Cellular Dynamics International, Inc., incorporated on November 16, 2007, develops and manufactures fully functioning human cells in industrial quantities to precise specifications. The Company�� iCell Operating System (iCell O/S) includes true human cells in multiple cell types (iCell products), human induced pluripotent stem cells (iPSCs) and custom iPSCs and iCell products (MyCell products). Customers use its iCell O/S products, among other purposes, for drug discovery and screening; to test the safety and efficacy of their small molecule and biologic drug candidates; for stem cell banking; and in researching cellular therapeutics. The Company�� iCell product line includes four different cell types: cardiomyocytes, neurons, hepatocytes and endothelial cells. The Company is actively developing an additional seven different cell types. iCell products are a consumable designed to be used once and then reordered.

The Company manufactures its iCell products from its iPSCs. An iPSC is a cell that has the ability both to replicate indefinitely and to be transformed into any cell type in the human body. The Company�� iCell O/S consists of six products, which include iCell Cardiomyocytes, iCell Neurons, iCell Endothelial Cells, iCell Hepatocytes and MyCell.

Advisors' Opinion:
  • [By John Udovich]

    Stem cells may not be in the news much�as the sector has moved beyond the use of embryotic�ones, but small cap stem cell stocks Cellular Dynamics International Inc (NASDAQ: ICEL), International Stem Cell Corp (OTCMKTS: ISCO) and BioRestorative Therapies (OTCBB: BRTX) have been fairly active over the past several trading days as ICEL went public, ISCO raised additional funding and BRTX grabbed more attention:

Hot Tech Stocks To Invest In Right Now: bluebird bio Inc (BLUE)

bluebird bio, Inc., incorporated on April 16, 1992, is a clinical-stage biotechnology company, the Company is focused on transforming the lives of patients with severe genetic and orphan diseases using gene therapy. Gene therapy seeks to introduce a functional copy of the defective gene into a patient�� own cells, a process called gene transfer. Through gene transfer, a functional copy of the mutated gene is delivered to the patient�� cells, thereby correcting the underlying genetic defect that causes aberrant gene expression. As of December 31, 2012, the Company is conducting a Phase I/II clinical study in France evaluating an earlier generation of its LentiGlobin vector for the treatment of �-thalassemia major and SCD. Initial proof-of-concept data from this study were published in Nature. During the year ended December 31, 2013, the Company plans to initiate an extension of this study under a revised protocol for LentiGlobin, which the Company refers to as the HGB-205 Study. The Company also plans o initiate a second Phase I/II clinical program in the United States for LentiGlobin, which the Company refers to as the HGB-204 Study, for �-thalassemia major. In March 2013, the Company entered into a strategic collaboration with Celgene Corporation, or Celgene, to discover, develop and commercialize, disease-altering gene therapies in oncology.

Its gene therapy platform is based on viral vectors that utilize a modified, non-replicating version of the Human Immunodeficiency Virus Type 1 (HIV-1) virus, that has been stripped of all of the components required for it to self-replicate and infect additional cells. The HIV-1 virus is part of the lentivirus family of viruses, as a result of which the Company refer to its vectors as lentiviral vectors. Its lentiviral vectors are used to introduce a functional copy of a gene to the patient�� own isolated blood stem cells, called hematopoietic stem cells (HSCs), which reside in a patient�� bone marrow and are capable of differentiating int! o a wide range of cell types. HSCs are dividing cells, thus its approach allows for sustained expression of the modified gene as the Company is able to take advantage of a lifetime of replication of the gene-modified HSCs. Additionally, the Company has developed a cell-based vector manufacturing process that is both reproducible and scalable.

Adrenoleukodystrophy

Adrenoleukodystrophy is a rare X-linked, inherited, neurological disorder that is often fatal. ALD is caused by mutations in the ABCD1 gene which encodes for a protein called the ALD protein (ALDP), which plays a critical role in the breakdown and metabolism of long-chain fatty acids (VLCFA). Without functional ALDP, VLCFA accumulate in cells including neural cells in which they cause damage to the myelin sheath, a protective and insulating membrane that surrounds nerve cells in the brain. This damage can result in decreased motor coordination and function, visual and hearing disturbances, the loss of cognitive function, dementia, seizures, adrenal dysfunction and other complications, including death. ALD is divided into various sub-segments with three main phenotypes that impact brain function: CCALD (Childhood cerebral adrenoleukodystrophy, AMN (Adrenomyeloneuropathy) and ACALD (Adult Cerebral ALD).

�-thalassemia

�-thalassemia is a rare hereditary blood disorder caused by a genetic abnormality of the �-globin gene resulting in defective red blood cells (RBCs). Genetic mutations cause the absence or reduced production of the beta chains of hemoglobin, or �-globin, thereby preventing the proper formation of hemoglobin A, which normally accounts for greater than 95% of the hemoglobin in the blood of adults. Hemoglobin is an iron-containing protein in the blood that carries oxygen from the respiratory organs to the rest of the body. Hemoglobin A consists of four chains-two chains each of a-globin and �-globin. Normally existing at an approximate 1:1 ratio, genetic mutations that impair t! he produc! tion of �-globin can lead to a relative excess of a-globin, premature death of red blood cells. The clinical implications of the a-globin/�-globin imbalance are two-fold: first, patients lack sufficient RBCs and hemoglobin to effectively transport oxygen throughout the body and can become severely anemic; and second, the shortened life span and ineffective production of RBCs can lead to other complications such as splenomegaly, marrow expansion, bone deformities, and iron overload in organs.

Sickle cell disease

Sickle cell disease (SCD) is a hereditary blood disorder resulting from a mutation in the �-globin gene that causes polymerization of hemoglobin proteins and abnormal red blood cell function. The disease is characterized by anemia, vaso-occlusive pain crisis (a common complication of SCD in which there is severe pain due to obstructed blood flow in the bones, joints, lungs, liver, spleen, kidney, eye, or central nervous system), infections, stroke, overall poor life and early death in a subset of patients. Under low-oxygen conditions, which are exacerbated by the red blood cell abnormalities, the mutant hemoglobin aggregates causing the RBCs to take on a sickle shape (sickle cells), which causes them to aggregate and obstruct small blood vessels, thereby restricting blood flow to organs resulting in pain, cell death and organ damage. If oxygen levels are restored, the hemoglobin can disaggregate and the RBCs return to their normal shape, but over time, the sickling damages the cell membrane and the cells fail to return to the normal shape even in high-oxygen conditions.

Advisors' Opinion:
  • [By Jay Silverman]

    Some of the biggest leaders in that field, and there have been dozens in fields, if not more this year, such as Bluebird (BLUE) and Stemline Therapeutics (STML) and have all pulled back to significantly lower levels; even below, in Bluebird's case, the price that had actually opened up as an IPO, even though it's above its IPO price.

  • [By Garrett Cook]

    Bluebird Bio (NASDAQ: BLUE) shares shot up 33.61 percent to $34.86 following the presentation of positive data on LentiGlobin BB305 at the European Hematology Association (EHA).

No comments:

Post a Comment